Immatics NV (Immatics NV) Other Gross PPE : $67.23 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Other Gross PPE?

Immatics NV's Other Gross PPE for the quarter that ended in Mar. 2024 was $67.23 Mil.

Immatics NV's quarterly Other Gross PPE declined from Sep. 2023 ($52.45 Mil) to Dec. 2023 ($43.04 Mil) but then increased from Dec. 2023 ($43.04 Mil) to Mar. 2024 ($67.23 Mil).

Immatics NV's annual Other Gross PPE increased from Dec. 2021 ($22.98 Mil) to Dec. 2022 ($24.52 Mil) and increased from Dec. 2022 ($24.52 Mil) to Dec. 2023 ($43.04 Mil).

Immatics NV Other Gross PPE Historical Data

The historical data trend for Immatics NV's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV Other Gross PPE Chart

Immatics NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

14.19

19.48

22.98

24.52

43.04

Immatics NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															31.69	45.44	52.45	43.04	67.23

Immatics NV Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Immatics NV (Immatics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

4A3:Germany

Address

Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.immatics.com

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.